Biguanides

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC A10BA
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector BIGUANIDES

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 32965 14939 18026
Unadjusted prevalence (%) 12.68 10.17 15.94
Mean age at first event (years) 59.39 58.40 60.22

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.45 [2.17, 2.76] 5.0e-49 4293
15 years 0.02 2.59 [2.34, 2.87] 2.5e-75 3637
5 years 0.00 2.94 [2.66, 3.25] 5.2e-99 1175
1 year 0.00 1.85 [1.50, 2.28] 5.7e-9 135

Correlations

Index endpoint: BIGUANIDES – Biguanides
GWS hits:

Survival analyses between endpoints

Plot

before Biguanides
after Biguanides

loading spinner Loading survival analyses plot